Login
E-mail
Password
Mostra password
Ricorda
Password dimenticata?
Iscriviti gratuitamente
Registrazione
Registrazione
Parametri
Parametri
Quotazioni dinamiche 
OFFON
  1. Home
  2. Azioni
  3. Hong Kong
  4. Hong Kong Stock Exchange
  5. Ocumension Therapeutics
  6. SocietÓ
    1477   KYG674111011

OCUMENSION THERAPEUTICS

(1477)
Prezzo di chiusura. Prezzo di chiusura Hong Kong Stock Exchange - 15/10
18.56 HKD   +1.75%
RiassuntoGraficiRatingAgendaSocietÓFinanzaConsensusRevisioni 
AttivitÓ
Ocumension Therapeutics Ŕ una holding con sede in Cina che si occupa principalmente della scoperta, dello sviluppo e della commercializzazione di terapie oftalmiche. I suoi prodotti principali includono, tra gli altri, OT-401 (YUTIQ), OT-1001 (ZERVIATE), OT-502 (DEXYCU), OT-301 (NCX 470), OT-101 e OT-202. La SocietÓ svolge la propria attivitÓ sul mercato nazionale.

Numero di dipendenti : 136 persone.
Vendite per attivitÓ
20192020Delta
Ophthalmic Pharmaceutical Platform0.22100%14.72100% +6730.5%
HKD in Milioni
Vendite per regione
20192020Delta
China0.22100%14.72100% +6730.5%
HKD in Milioni
Dirigenti
Nome Titolo EtÓ Da
Ye Liu Chief Executive Officer & Executive Director 49 2018
Jian Ping Yang Finance Director - -
Chang Dong Liu, Dr. Chief Scientific Officer 58 2019
Dong Hong Chen, Dr. Chief Medical Officer 49 2019
Jie Ting Jiang Director-Human Resources & Administration - -
Ting Yuk Wu Independent Non-Executive Director 65 2020
Lian Ming He Independent Non-Executive Director 55 -
Yi Ran Huang Independent Non-Executive Director 65 -
Yun Ji Secretary & Director-Strategic Project - 2020
Pui Chun Suen Secretary 41 2020
Amministratori
Nome Titolo EtÓ Da
Lian Yong Chen, Dr. Non-Executive Chairman 57 2021
Ye Liu Chief Executive Officer & Executive Director 49 2018
Shen Ye Director - -
Qin Xie Member-Supervisory Board - -
Zhao Peng Hu, Dr. Executive Director & VP-Regulatory Affairs 47 2020
Wei Li, Dr. Non-Executive Director 48 2021
Yan Ling Cao Non-Executive Director 36 2019
Ting Yuk Wu Independent Non-Executive Director 65 2020
Lian Ming He Independent Non-Executive Director 55 -
Yi Ran Huang Independent Non-Executive Director 65 -
Azioni
Voto QuantitÓFlottanteAutocontrolloFlottante totale
Azione A 1 639 314 175 278 228 972 43.5% 0 0.0% 43.5%
Azionisti
NomeAzioni%
Suzhou Yunchang Investment Consulting Co. Ltd. 130 500 000 20,7%
6 Dimensions Capital 126 200 000 20,0%
Boyu Capital Advisory Co. Ltd. 78 214 230 12,4%
Temasek Holdings Pte Ltd. (Investment Management) 54 169 400 8,58%
Capital Research & Management Co. (World Investors) 47 963 490 7,60%
FIL Investment Management (Hong Kong) Ltd. 18 342 746 2,91%
Capital Research & Management Co. (Global Investors) 9 650 966 1,53%
Ye Liu 5 836 730 0,92%
UBS Asset Management (Hong Kong) Ltd. 4 227 000 0,67%
Zhao Peng Hu 2 820 243 0,45%
Partecipazioni
NomeAzioni%Valorizzazione
EYEPOINT PHARMACEUTICALS, INC. (EYPT) 3 010 722 10,5% 32 937 299 USD
ALIMERA SCIENCES, INC. (ALIM) 1 144 945 16,5% 6 858 221 USD
Portafoglio di marchi
In collaborazione conAllbrands.markets
Pi¨ marchi di Ocumension Therapeutics
Settore Prodotti farmaceutici - Altri
Var. 1genCapi. (M$)
OCUMENSION THERAPEUTICS-31.26%1 525
JOHNSON & JOHNSON2.49%424 619
ROCHE HOLDING AG16.59%339 442
NOVO NORDISK A/S54.22%234 792
PFIZER, INC.13.20%232 621
ELI LILLY AND COMPANY40.89%215 657
MERCK & CO., INC.-4.24%198 283
ABBVIE INC.2.03%193 205
ASTRAZENECA PLC20.08%187 492
NOVARTIS AG-8.03%186 330
BRISTOL-MYERS SQUIBB COMPANY-5.92%129 683
SANOFI6.53%122 086
AMGEN INC.-9.60%118 022
GLAXOSMITHKLINE PLC4.29%96 396
ALLERGAN PLC0.97%63 659
CHUGAI PHARMACEUTICAL CO., LTD.-27.49%57 462
BAYER AG-0.56%54 575
JIANGSU HENGRUI MEDICINE CO., LTD.-46.12%49 566
DAIICHI SANKYO COMPANY, LIMITED-16.76%49 400
TAKEDA PHARMACEUTICAL COMPANY LIMITED-13.93%44 517
ASTELLAS PHARMA INC.25.60%32 494